Clinical Trials
9
Active:0
Completed:3
Trial Phases
2 Phases
Phase 1:4
Phase 2:5
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Phase 2
5 (55.6%)Phase 1
4 (44.4%)BMX-001 + Paclitaxel in Adult Patients With Advanced, Recurrent, Metastatic Ovarian or Endometrial Cancer
Phase 1
Not yet recruiting
- Conditions
- Ovarian NeoplasmsEndometrial Cancer, Endometrial Neoplasm
- Interventions
- First Posted Date
- 2024-10-01
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- BioMimetix JV, LLC
- Target Recruit Count
- 27
- Registration Number
- NCT06620029
- Locations
- 🇺🇸
Duke Cancer Institute, Durham, North Carolina, United States
A Clinical Trial of BMX-010 in Adult Subjects With Atopic Dermatitis
- First Posted Date
- 2022-08-08
- Last Posted Date
- 2024-04-18
- Lead Sponsor
- BioMimetix JV, LLC
- Target Recruit Count
- 103
- Registration Number
- NCT05491447
- Locations
- 🇺🇸
Cahaba Dermatology & Skin Health Center, Birmingham, Alabama, United States
🇺🇸Dermatology Trial Associates, Bryant, Arkansas, United States
🇺🇸Johnson Dermatology, Fort Smith, Arkansas, United States
Trial of BMX-001 or Placebo in Head and Neck Cancer Patients
Phase 2
Withdrawn
- Conditions
- Head and Neck Cancer
- Interventions
- First Posted Date
- 2020-10-29
- Last Posted Date
- 2021-10-11
- Lead Sponsor
- BioMimetix JV, LLC
- Registration Number
- NCT04607642
Evaluation of Topical Application of BMX-010 in Subjects With Rosacea
- First Posted Date
- 2018-11-28
- Last Posted Date
- 2022-09-28
- Lead Sponsor
- BioMimetix JV, LLC
- Target Recruit Count
- 60
- Registration Number
- NCT03756389
- Locations
- 🇺🇸
Colorado Skin Care, Englewood, Colorado, United States
Evaluation of Topical Application of BMX-010 in Subjects With Acne Vulgaris.
Phase 2
Terminated
- Conditions
- Acne Vulgaris
- Interventions
- Drug: BMX-010 0.3%
- First Posted Date
- 2018-11-23
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- BioMimetix JV, LLC
- Target Recruit Count
- 2
- Registration Number
- NCT03752242
- Locations
- 🇺🇸
Colorado Skin Care, Englewood, Colorado, United States
- Prev
- 1
- 2
- Next
News
No news found